Endoron Medical, a pioneering medtech firm specializing in innovative endograft stapling solutions for abdominal aortic aneurysms (AAA), has successfully closed a $10 million Series A funding round. Sofinnova Partners led…
Centene Corporation (NYSE: CNC), a prominent healthcare enterprise dedicated to promoting healthier lifestyles, announced today that it will unveil its 2024 second quarter financial results at around 6:00 a.m. ET…
Atara Biotherapeutics, Inc. (Nasdaq: ATRA) has granted 2,200 restricted stock units of its common stock to a newly hired employee. Approved by the Compensation Committee of Atara’s Board of Directors,…
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that the U.S. Food and Drug Administration (FDA) has approved Vabysmo® (faricimab-svoa) 6.0 mg single-dose prefilled…
TauRx Pharmaceuticals Ltd, a leader in tau-based research for Alzheimer’s disease (AD), has submitted a UK Marketing Authorisation Application (MAA) for hydromethylthionine mesylate (HMTM) to treat mild cognitive impairment (MCI-AD)…
Mitel®, a global leader in business communications, has announced that its Virtual Care Collaboration Service (VCCS) has earned the prestigious title of “Virtual Workspace Platform of the Year” in the…
Pulse Biosciences, Inc. (Nasdaq: PLSE), leveraging its CellFX® Nanosecond Pulsed Field Ablation™ (nsPFA™) technology, disclosed today the preliminary outcomes of its recently concluded rights offering. The offering, which expired at…
Tebra, the comprehensive platform for independent healthcare providers, has announced multiple new product enhancements in the second quarter aimed at maximizing time spent with patients. This announcement coincides with the…
Swift Medical, a leading digital health technology company specializing in enhancing clinical outcomes in chronic and acute wound care, is pleased to announce the appointment of Dwayne Sansone as Chief…
TVM Capital Healthcare has announced a USD 35 million investment in Boston Oncology Arabia, a bio-generic drugs manufacturer based in Saudi Arabia. Headquartered in Riyadh with a production facility in…
“Bristol Myers Squibb (NYSE: BMY) announced today that the U.S. Food and Drug Administration (FDA) has granted accelerated approval for KRAZATI® (adagrasib) in combination with cetuximab as a targeted treatment…
Insulet Corporation (NASDAQ: PODD), a leader in tubeless insulin pump technology under the Omnipod® brand, has unveiled positive outcomes from its pivotal trial of the Omnipod 5 Automated Insulin Delivery…